These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7549606)

  • 21. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Willebrand disease: a laboratory approach.
    Trasi S; Ghosh K; Shetty S; Mohanty D
    Natl Med J India; 2005; 18(2):78-84. PubMed ID: 15981443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [von Willebrand's disease].
    Mezzano D; Pereira J; Quiroga T
    Rev Med Chil; 1990 Mar; 118(3):320-9. PubMed ID: 2131515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological diagnosis of Von Willebrand disease and its difficulties].
    Znazen R; Guermazi S; Karoui M
    Tunis Med; 2007 Jun; 85(6):445-9. PubMed ID: 17644894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches in the measurement of coagulation.
    Ingerslev J; Sørensen B; Castaman G; Lloyd JV; Varon JD; Savion N
    Haemophilia; 2008 Jul; 14 Suppl 3():104-12. PubMed ID: 18510529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of von Willebrand's disease subtypes by the analysis of multimeric composition of plasma von Willebrand factor].
    Quiroga T; Pérez M; Pereira J; Mezzano D
    Rev Med Chil; 1993 Sep; 121(9):987-93. PubMed ID: 8191164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory screening and diagnosis of von Willebrand's disease.
    Schlammadinger A; Boda Z
    Clin Lab; 2002; 48(7-8):385-93. PubMed ID: 12146572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory tests for precise classification and genetic analysis of von Willebrand disease.
    Habart D; Vorlová Z
    Sb Lek; 2003; 104(2):237-45. PubMed ID: 14577134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the von Willebrand factor with platelets and thrombosis.
    Perutelli P; Mori PG
    Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. von Willebrand's factor and von Willebrand's disease.
    Matsushita T; Dong Z; Sadler JE
    Curr Opin Hematol; 1994 Sep; 1(5):362-8. PubMed ID: 9371306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human chimera for von Willebrand disease following bone marrow transplantation.
    Ware RE; Parker RI; McKeown LP; Graham ML
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):338-42. PubMed ID: 8328650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.
    Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y
    J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.